In Brief: L-cysteine toxicity
This article was originally published in The Tan Sheet
Executive Summary
L-cysteine toxicity: Tyson and Associates submits June 14 letter to FDA in support of a generally recognized as safe (GRAS) petition filed by Skymart Enterprises for L-cysteine. After conducting a literature review, Tyson concluded that "L-cysteine should essentially be taken under a doctor's supervision for children under 12 years old, and that it should not be removed from the marketplace. However, providing a better professional nutritional safe dose is recommended." Tyson previously conducted a literature search to support the safety of amino acids ("The Tan Sheet" Aug. 30, 1993, p. 16)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning